Selected research
Industry Research
Bacterial Serotyping - Antisera Industry Research Report 2026
Market perspective
The global Bacterial Serotyping - Antisera market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bacterial Serotyping - Antisera is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bacterial Serotyping - Antisera is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bacterial Serotyping - Antisera is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bacterial Serotyping - Antisera include Arlington Scientific, BioMérieux, Bio-Rad, Biotec, Cardinal Health, Gold Standard Diagnostics, Hardy Diagnostics, Mast Group and Microgen Bioproducts, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bacterial Serotyping - Antisera market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bacterial Serotyping - Antisera Market by Company
Arlington Scientific
BioMérieux
Bio-Rad
Biotec
Cardinal Health
Gold Standard Diagnostics
Hardy Diagnostics
Mast Group
Microgen Bioproducts
Pro Lab Diagnostics
Thermo Fisher
Bacterial Serotyping - Antisera Segment by Type
Shigella
Yersinia
Pseudomonas Aeruginosa
Salmonella
Enterobacter
Bacterial Serotyping - Antisera Segment by Application
Food and Industrial Microbiology
Clinical Diagnosis
Others
Bacterial Serotyping - Antisera Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacterial Serotyping - Antisera market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bacterial Serotyping - Antisera and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacterial Serotyping - Antisera.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bacterial Serotyping - Antisera manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bacterial Serotyping - Antisera by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bacterial Serotyping - Antisera in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Shigella
- Yersinia
- Pseudomonas Aeruginosa
- Salmonella
- Enterobacter
Applications
- Food and Industrial Microbiology
- Clinical Diagnosis
- Others
Companies covered
- Arlington Scientific
- BioMérieux
- Bio-Rad
- Biotec
- Cardinal Health
- Gold Standard Diagnostics
- Hardy Diagnostics
- Mast Group
- Microgen Bioproducts
- Pro Lab Diagnostics
- Thermo Fisher
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bacterial Serotyping - Antisera Market Size (2021-2032)
- 2.2.2 Global Bacterial Serotyping - Antisera Sales (2021-2032)
- 2.2.3 Global Bacterial Serotyping - Antisera Market Average Price (2021-2032)
- 2.3 Bacterial Serotyping - Antisera by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Shigella
- 2.3.3 Yersinia
- 2.3.4 Pseudomonas Aeruginosa
- 2.3.5 Salmonella
- 2.3.6 Enterobacter
- 2.4 Bacterial Serotyping - Antisera by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Food and Industrial Microbiology
- 2.4.3 Clinical Diagnosis
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bacterial Serotyping - Antisera Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bacterial Serotyping - Antisera Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Bacterial Serotyping - Antisera Revenue of Manufacturers (2021-2026)
- 3.4 Global Bacterial Serotyping - Antisera Average Price by Manufacturers (2021-2026)
- 3.5 Global Bacterial Serotyping - Antisera Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bacterial Serotyping - Antisera, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bacterial Serotyping - Antisera, Product Type & Application
- 3.8 Global Manufacturers of Bacterial Serotyping - Antisera, Established Date
- 3.9 Global Bacterial Serotyping - Antisera Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Arlington Scientific
- 4.1.1 Arlington Scientific Company Information
- 4.1.2 Arlington Scientific Business Overview
- 4.1.3 Arlington Scientific Bacterial Serotyping - Antisera Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Arlington Scientific Bacterial Serotyping - Antisera Product Portfolio
- 4.1.5 Arlington Scientific Recent Developments
- 4.2 BioMérieux
- 4.2.1 BioMérieux Company Information
- 4.2.2 BioMérieux Business Overview
- 4.2.3 BioMérieux Bacterial Serotyping - Antisera Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BioMérieux Bacterial Serotyping - Antisera Product Portfolio
- 4.2.5 BioMérieux Recent Developments
- 4.3 Bio-Rad
- 4.3.1 Bio-Rad Company Information
- 4.3.2 Bio-Rad Business Overview
- 4.3.3 Bio-Rad Bacterial Serotyping - Antisera Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bio-Rad Bacterial Serotyping - Antisera Product Portfolio
- 4.3.5 Bio-Rad Recent Developments
- 4.4 Biotec
- 4.4.1 Biotec Company Information
- 4.4.2 Biotec Business Overview
- 4.4.3 Biotec Bacterial Serotyping - Antisera Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Biotec Bacterial Serotyping - Antisera Product Portfolio
- 4.4.5 Biotec Recent Developments
- 4.5 Cardinal Health
- 4.5.1 Cardinal Health Company Information
- 4.5.2 Cardinal Health Business Overview
- 4.5.3 Cardinal Health Bacterial Serotyping - Antisera Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Cardinal Health Bacterial Serotyping - Antisera Product Portfolio
- 4.5.5 Cardinal Health Recent Developments
- 4.6 Gold Standard Diagnostics
- 4.6.1 Gold Standard Diagnostics Company Information
- 4.6.2 Gold Standard Diagnostics Business Overview
- 4.6.3 Gold Standard Diagnostics Bacterial Serotyping - Antisera Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Gold Standard Diagnostics Bacterial Serotyping - Antisera Product Portfolio
- 4.6.5 Gold Standard Diagnostics Recent Developments
- 4.7 Hardy Diagnostics
- 4.7.1 Hardy Diagnostics Company Information
- 4.7.2 Hardy Diagnostics Business Overview
- 4.7.3 Hardy Diagnostics Bacterial Serotyping - Antisera Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hardy Diagnostics Bacterial Serotyping - Antisera Product Portfolio
- 4.7.5 Hardy Diagnostics Recent Developments
- 4.8 Mast Group
- 4.8.1 Mast Group Company Information
- 4.8.2 Mast Group Business Overview
- 4.8.3 Mast Group Bacterial Serotyping - Antisera Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mast Group Bacterial Serotyping - Antisera Product Portfolio
- 4.8.5 Mast Group Recent Developments
- 4.9 Microgen Bioproducts
- 4.9.1 Microgen Bioproducts Company Information
- 4.9.2 Microgen Bioproducts Business Overview
- 4.9.3 Microgen Bioproducts Bacterial Serotyping - Antisera Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Microgen Bioproducts Bacterial Serotyping - Antisera Product Portfolio
- 4.9.5 Microgen Bioproducts Recent Developments
- 4.10 Pro Lab Diagnostics
- 4.10.1 Pro Lab Diagnostics Company Information
- 4.10.2 Pro Lab Diagnostics Business Overview
- 4.10.3 Pro Lab Diagnostics Bacterial Serotyping - Antisera Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pro Lab Diagnostics Bacterial Serotyping - Antisera Product Portfolio
- 4.10.5 Pro Lab Diagnostics Recent Developments
- 4.11 Thermo Fisher
- 4.11.1 Thermo Fisher Company Information
- 4.11.2 Thermo Fisher Business Overview
- 4.11.3 Thermo Fisher Bacterial Serotyping - Antisera Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Thermo Fisher Bacterial Serotyping - Antisera Product Portfolio
- 4.11.5 Thermo Fisher Recent Developments
5 Global Bacterial Serotyping - Antisera Market Scenario by Region
- 5.1 Global Bacterial Serotyping - Antisera Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bacterial Serotyping - Antisera Sales by Region: 2021-2032
- 5.2.1 Global Bacterial Serotyping - Antisera Sales by Region: 2021-2026
- 5.2.2 Global Bacterial Serotyping - Antisera Sales by Region: 2027-2032
- 5.3 Global Bacterial Serotyping - Antisera Revenue by Region: 2021-2032
- 5.3.1 Global Bacterial Serotyping - Antisera Revenue by Region: 2021-2026
- 5.3.2 Global Bacterial Serotyping - Antisera Revenue by Region: 2027-2032
- 5.4 North America Bacterial Serotyping - Antisera Market Facts & Figures by Country
- 5.4.1 North America Bacterial Serotyping - Antisera Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bacterial Serotyping - Antisera Sales by Country (2021-2032)
- 5.4.3 North America Bacterial Serotyping - Antisera Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Bacterial Serotyping - Antisera Market Facts & Figures by Country
- 5.5.1 Europe Bacterial Serotyping - Antisera Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bacterial Serotyping - Antisera Sales by Country (2021-2032)
- 5.5.3 Europe Bacterial Serotyping - Antisera Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Bacterial Serotyping - Antisera Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bacterial Serotyping - Antisera Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bacterial Serotyping - Antisera Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bacterial Serotyping - Antisera Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bacterial Serotyping - Antisera Market Facts & Figures by Country
- 5.7.1 South America Bacterial Serotyping - Antisera Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bacterial Serotyping - Antisera Sales by Country (2021-2032)
- 5.7.3 South America Bacterial Serotyping - Antisera Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Bacterial Serotyping - Antisera Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bacterial Serotyping - Antisera Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bacterial Serotyping - Antisera Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bacterial Serotyping - Antisera Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Bacterial Serotyping - Antisera Sales by Type (2021-2032)
- 6.1.1 Global Bacterial Serotyping - Antisera Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Bacterial Serotyping - Antisera Sales Market Share by Type (2021-2032)
- 6.2 Global Bacterial Serotyping - Antisera Revenue by Type (2021-2032)
- 6.2.1 Global Bacterial Serotyping - Antisera Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bacterial Serotyping - Antisera Revenue Market Share by Type (2021-2032)
- 6.3 Global Bacterial Serotyping - Antisera Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bacterial Serotyping - Antisera Sales by Application (2021-2032)
- 7.1.1 Global Bacterial Serotyping - Antisera Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Bacterial Serotyping - Antisera Sales Market Share by Application (2021-2032)
- 7.2 Global Bacterial Serotyping - Antisera Revenue by Application (2021-2032)
- 7.2.1 Global Bacterial Serotyping - Antisera Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bacterial Serotyping - Antisera Revenue Market Share by Application (2021-2032)
- 7.3 Global Bacterial Serotyping - Antisera Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bacterial Serotyping - Antisera Value Chain Analysis
- 8.1.1 Bacterial Serotyping - Antisera Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bacterial Serotyping - Antisera Production Mode & Process
- 8.2 Bacterial Serotyping - Antisera Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bacterial Serotyping - Antisera Distributors
- 8.2.3 Bacterial Serotyping - Antisera Customers
9 Global Bacterial Serotyping - Antisera Analyzing Market Dynamics
- 9.1 Bacterial Serotyping - Antisera Industry Trends
- 9.2 Bacterial Serotyping - Antisera Industry Drivers
- 9.3 Bacterial Serotyping - Antisera Industry Opportunities and Challenges
- 9.4 Bacterial Serotyping - Antisera Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst